Neonatal screening for congenital adrenal hyperplasia in Japan

Toshihiro Tajima1, Kaori Fujikura, Masaru Fukushi

  • 1Department of Pediatrics, Hokkaido University School of Medicine, N15, W7, Kita-Ku, Sapporo 060-8638, Japan. tajeari@med.hokudai.ac.jp

Insights

Congenital adrenal hyperplasia (CAH) screening in Japan uses advanced methods like LC-MS/MS to improve accuracy. This technology enhances early detection and treatment effectiveness for newborns, particularly preterm infants.

Area of Science:

  • Endocrinology
  • Genetics
  • Neonatal screening

Background:

  • Congenital adrenal hyperplasia (CAH) screening has been conducted nationwide in Japan since 1989.
  • The incidence of 21-hydroxylase deficiency in Japan is approximately 1/18,000, comparable to global rates.
  • Cost-benefit analyses confirm the effectiveness of early CAH detection and treatment in Japan.

Purpose of the Study:

  • To address the high false-positive rates in CAH screening for preterm infants.
  • To enhance the positive predictive value of newborn screening for CAH.
  • To evaluate and suggest improved screening methodologies for CAH in Japan.

Main Methods:

  • Utilized 21-hydroxylase gene (CYP21A2) analysis on dried blood spots.
  • Employed high-performance liquid chromatography (HPLC) for 17-hydroxyprogesterone measurement.
  • Implemented tandem mass spectrometry (LC-MS/MS) as a current screening technique.

Main Results:

  • The study highlights the ongoing efforts to refine CAH screening protocols.
  • LC-MS/MS has been adopted to improve the accuracy of screening.
  • The incidence of CAH in Japan is consistent with international data.

Conclusions:

  • Tandem mass spectrometry (LC-MS/MS) is recommended for future CAH screening in Japan.
  • Improving screening accuracy is crucial for effective early detection and management of CAH.
  • Continued advancements in screening technology are vital for neonatal health outcomes.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...